SCHEMBL25205778

SCHEMBL25205778

O=C(N[C@H]1CC[C@H](O)CC1)c1csc(-c2cnn(-c3ccccc3)c2)n1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 1/20 0.47
HTR3B O95264 1/20 0.47
CHRNA7 P36544 1/20 0.47
HTR3A P46098 1/20 0.47
HTR3D Q70Z44 1/20 0.47
HTR3C Q8WXA8 1/20 0.47
TNKS O95271 2/20 0.47
PDE4B Q07343 2/20 0.46
PIM1 P11309 2/20 0.45
ACKR3 P25106 3/20 0.44
PIN1 Q13526 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
RIPK2 O43353 4/20 0.42
TYR P14679 1/20 0.42
CLK2 P49760 1/20 0.41
LRRK2 Q5S007 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25267175 1.00 HTR3E (0.47) HTR3EHTR3BCHRNA7HTR3AHTR3D
SCHEMBL25233750 0.91 PIN1 (0.53) HTR3EHTR3BCHRNA7HTR3AHTR3D
SCHEMBL25233845 0.89 HTR3E (0.46) HTR3EHTR3BCHRNA7HTR3AHTR3D
SCHEMBL31370641 0.89 KHK (0.47) HTR3EHTR3BCHRNA7HTR3AHTR3D
SCHEMBL25206061 0.88 HTR3E (0.48) HTR3EHTR3BCHRNA7HTR3AHTR3D
SCHEMBL25205187 0.87 HTR3E (0.45) HTR3EHTR3BCHRNA7HTR3AHTR3D
SCHEMBL25245499 0.87 KHK (0.45) HTR3EHTR3BCHRNA7HTR3AHTR3D
SCHEMBL25230854 0.86 HTR3E (0.45) HTR3EHTR3BCHRNA7HTR3AHTR3D
SCHEMBL25230853 0.86 HTR3E (0.45) HTR3EHTR3BCHRNA7HTR3AHTR3D
SCHEMBL31090060 0.86 ACKR3 (0.49) HTR3EHTR3BCHRNA7HTR3AHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250034127-A1 AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF, IN PARTICULAR FOR DISEASES OF THE CNS UNIVERSITÉ PARIS CITÉ (FR) 2025-01-30 US claimed
EP-4183449-A1 AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF Samsara Therapeutics Inc. (US) 2023-05-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250034127-A1 AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF, IN PARTICULAR FOR DISEASES OF THE CNS SQSTM1, TFEB, BECN1 HTR3E 1398/4885HTR3B 1378/4885CHRNA7 1846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.